文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Exploratory Research: Patient-Reported Factors Contributing to Decreased Oral Intake During Radiotherapy in Head and Neck Cancer.

作者信息

Vergauwen Alice, Baudelet Margot, Van den Steen Leen, Goeleven Ann, Nuyts Sandra, Nevens Daan, Massonet Hanne, Duprez Fréderic, Van Nuffelen Gwen

机构信息

Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Faculty of Medicine and Health Sciences, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.

出版信息

Head Neck. 2025 Jun;47(6):1717-1725. doi: 10.1002/hed.28089. Epub 2025 Jan 24.


DOI:10.1002/hed.28089
PMID:39854098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12068540/
Abstract

BACKGROUND: Radiotherapy (RT) in head and neck cancer (HNC) can cause multiple side effects such as nausea, pain, taste loss, fatigue, oral mucositis, xerostomia, and acute radiation-associated dysphagia (RAD). These factors threaten patients' oral intake (OI) during this RT. Reduced OI can cause weight loss, dehydration, malnutrition, and various comorbidities. On top, reduced OI significantly affects quality of life and may contribute to RAD through the disuse of swallowing muscles. With the aim of maximizing the retention of a patient's OI, it is important to gain an insight into the factors that have the greatest impact. Therefore, this study aims to identify the impact of contributing factors on decreased OI during RT. METHODS: During their treatment, 55 HNC patients completed an OI questionnaire at 5 different time points: during weeks 1, 2, 3, and 4 and at the end of RT (week 7). First, patients rated the OI compared to pre-RT on a 100 mm visual analogue scale (VAS). Subsequently, patients reported on separate VAS the degree to which pain, fatigue, loss of taste, loss of smell, loss of interest in food, nausea, and loss of hunger contributed to the decrease in OI (0: no contribution; 100: complete contribution). SPSS version 27 was used to analyze the results. RESULTS: OI decreased over time during RT, with the lowest OI at the end of RT. During the first 4 weeks of RT, the impact of all factors with pain, loss of taste, loss of interest in food, and loss of hunger pointed out as strongest contributing factors to a decreased OI. The most important patient-reported impacting factor on OI was loss of taste. At the end of RT, the importance of pain and nausea still increases, while the contribution of the other factors drops slightly. CONCLUSION: This cohort study shows that several factors contribute to a decreased OI in HNC patients during RT. This study is the first prospective analysis to identify self-reported factors contributing to reduced OI. Results demonstrate that taste has the greatest impact on OI followed by loss of interest in food, loss of hunger, and pain.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/481a/12068540/a03540e73104/HED-47-1717-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/481a/12068540/37e59b4ab5ba/HED-47-1717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/481a/12068540/a03540e73104/HED-47-1717-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/481a/12068540/37e59b4ab5ba/HED-47-1717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/481a/12068540/a03540e73104/HED-47-1717-g002.jpg

相似文献

[1]
Exploratory Research: Patient-Reported Factors Contributing to Decreased Oral Intake During Radiotherapy in Head and Neck Cancer.

Head Neck. 2025-6

[2]
Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.

J Cancer Surviv. 2018-3-20

[3]
Comparing the patients' subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires.

Acta Oncol. 2019-1-30

[4]
Monitoring Adverse Effects of Radiation Therapy in Patients With Head and Neck Cancer: The FACT-HN-RAD Patient-Reported Outcome Measure.

JAMA Otolaryngol Head Neck Surg. 2023-10-1

[5]
The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.

BMC Cancer. 2021-10-13

[6]
Reliability of the electronic patient reported outcome measures for assessing xerostomia, dysphagia and quality of life in Spanish patients with head and neck cancer: a randomised crossover design.

Health Qual Life Outcomes. 2025-3-3

[7]
Patient-reported outcome during radiotherapy for head and neck cancer: the use of different PRO questionnaires.

Eur Arch Otorhinolaryngol. 2022-8

[8]
Malnutrition in Head and Neck Cancer: A Patient-reported Outcome Study.

Anticancer Res. 2023-4

[9]
Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.

Oral Oncol. 2018-7-3

[10]
Head and Neck Cancer Survivors' Experiences with Chronic Nutrition Impact Symptom Burden after Radiation: A Qualitative Study.

J Acad Nutr Diet. 2020-10

本文引用的文献

[1]
Rebamipide gargle and benzydamine gargle in prevention and management of chemo-radiotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients (randomized clinical trial).

BMC Oral Health. 2024-6-1

[2]
Nutritional prehabilitation in head and neck cancer: A systematic review of literature.

Clin Nutr ESPEN. 2023-12

[3]
Prophylactic Swallowing Therapy During Head-and-Neck Cancer Radiotherapy: Effect of Service-Delivery Mode and Overall Adherence Level on Swallowing Function and Muscle Strength-the PRESTO Trial.

Dysphagia. 2024-4

[4]
Impact of Swallowing Impairment on Quality of Life of Individuals with Dysphagia.

Indian J Otolaryngol Head Neck Surg. 2022-12

[5]
Increasing Adherence to Prophylactic Swallowing Exercises During Head and Neck Radiotherapy: The Multicenter, Randomized Controlled PRESTO-Trial.

Dysphagia. 2023-6

[6]
Pharmacological Management of Neuropathic Pain after Radiotherapy in Head and Neck Cancer Patients: A Systematic Review.

J Clin Med. 2022-8-19

[7]
Malnutrition screening in head and neck cancer patients with oropharyngeal dysphagia.

Clin Nutr ESPEN. 2021-8

[8]
A qualitative study about cancer outpatients' experiences with selective taste control of bread as a self-care intervention.

Nurs Open. 2022-11

[9]
Randomized trial on acute toxicities of weekly vs three-weekly cisplatin-based chemoradiation in head and neck cancer.

Cancer Rep (Hoboken). 2022-1

[10]
Radiation Induced Mucositis: What the Radiologist Needs to Know.

Curr Probl Diagn Radiol. 2021

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索